TickerFactsScreenerDevelopers

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$15.8K2010: -$815.4K2011: -$21.22M2012: -$8.13M2013: -$22.64M2014: -$12.04M2015: -$27.86M2016: -$53.64M2017: -$92.88M2018: -$128.26M2019: -$206.87M2020: -$261.94M2021: -$342.70M2022: -$398.88M2023: -$460.56M2024: -$395.28M2025: -$403.36M-$403.36M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$403.36M-2.0%
2024-$395.28M+14.2%
2023-$460.56M-15.5%
2022-$398.88M-16.4%
2021-$342.70M-30.8%
2020-$261.94M-26.6%
2019-$206.87M-61.3%
2018-$128.26M-38.1%
2017-$92.88M-73.2%
2016-$53.64M-92.5%
2015-$27.86M-131.4%
2014-$12.04M+46.8%
2013-$22.64M-178.4%
2012-$8.13M+61.7%
2011-$21.22M-2502.2%
2010-$815.4K-5070.0%
2009-$15.8K—